Pterostilbene Ameliorates Glycemic Control,Dyslipidemia and Liver Injury in Type 2 Diabetes Rats

被引：1
|
作者：
ZHANG Yu Jing [1 ]
SUN Hua Lei [1 ]
WANG Teng [1 ]
LIU Xin Xin [1 ]
LIU Chang [1 ]
SHEN Fang [1 ]
WANG Bing Ya [1 ]
DING Run Rong [1 ]
LIU Yi Ming [1 ]
HUANG Guo Yu [1 ]
LI Wen Jie [1 ]
LI Xing [1 ]
机构：
[1] Department of Nutrition and Hygiene, College of Public Health, Zhengzhou University
来源：
BiomedicalandEnvironmentalSciences | 2020年 / 33卷 / 05期
关键词：
PTE; Pterostilbene Ameliorates Glycemic Control; Dyslipidemia and Liver Injury in Type 2 Diabetes Rats;
D O I：
暂无
中图分类号：
R587.1 [糖尿病];
学科分类号：
摘要：
Type 2 diabetes mellitus(T2DM) is typified by the increment of chronic blood glucose levels that is caused by an absolute and/or a relative deficiency of insulin, accounts for 90% of diabetes and causes a range of complications[1]. It has been suggested that inflammation contributed to the pathogenesis of
引用
收藏
页码：365 / 368
页数：4
相关论文
共 50 条
  • [1] Pterostilbene Ameliorates Glycemic Control, Dyslipidemia and Liver Injury in Type 2 Diabetes Rats
    Zhang Yu Jing
    Sun Hua Lei
    Wang Teng
    Liu Xin Xin
    Liu Chang
    Shen Fang
    Wang Bing Ya
    Ding Run Rong
    Liu Yi Ming
    Huang Guo Yu
    Li Wen Jie
    Li Xing
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2020, 33 (05) : 365 - +
  • [2] Poorer glycemic control is associated with dyslipidemia in type 2 diabetes
    Brown, JB
    Nichols, GA
    Hayes, RP
    Bowman, L
    DIABETES, 2004, 53 : A227 - A228
  • [3] Poorer glycemic control is associated with dyslipidemia in type 2 diabetes
    Nichols, GA
    Brown, JB
    Hayes, RP
    Bowman, L
    DIABETOLOGIA, 2004, 47 : A13 - A13
  • [4] GLYCEMIC CONTROL AND DIABETIC DYSLIPIDEMIA IN ADOLESCENTS WITH TYPE 2 DIABETES
    Phuong Thanh Le
    Huisingh, Carrie Ellen
    Ashraf, Ambika P.
    ENDOCRINE PRACTICE, 2013, 19 (06) : 972 - 979
  • [5] Antioxidant α-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes
    Ihara, Y
    Yamada, Y
    Toyokuni, S
    Miyawaki, K
    Ban, N
    Adachi, T
    Kuroe, A
    Iwakura, T
    Kubota, A
    Hiai, H
    Seino, Y
    FEBS LETTERS, 2000, 473 (01) : 24 - 26
  • [6] Atorvastatin ameliorates podocyte injury in patients with type 2 diabetes complicated with dyslipidemia
    Takemoto, Minoru
    Ishikawa, Takahiro
    Onishi, Shunichiro
    Okabe, Emiko
    Ishibashi, Ryoichi
    He, Peng
    Kobayashi, Kazuki
    Fujimoto, Masaki
    Kawamura, Harukiyo
    Yokote, Koutaro
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 (01) : E26 - E29
  • [7] Relationship of Serum γ-Glutamyltransferase to Atherogenic Dyslipidemia and Glycemic Control in Type 2 Diabetes
    Zoppini, Giacomo
    Targher, Giovanni
    Trombetta, Maddalena
    Lippi, Giuseppe
    Muggeo, Michele
    OBESITY, 2009, 17 (02) : 370 - 374
  • [8] Pioglitazone is superior to acarbose in improving glycemic control and dyslipidemia in patients with type 2 diabetes
    Göke, B
    DIABETOLOGIA, 2000, 43 : A193 - A193
  • [9] The effect of glycemic control in type 2 diabetic patients with diabetes-related dyslipidemia
    Abdel-Gayoum, AGA
    SAUDI MEDICAL JOURNAL, 2004, 25 (02) : 207 - 211
  • [10] The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus
    Rosenblatt, S
    Miskin, B
    Glazer, NB
    Prince, MJ
    Robertson, KE
    CORONARY ARTERY DISEASE, 2001, 12 (05) : 413 - 423
12345